Fluoroquinolone resistance among Mycobacterium tuberculosis strains from Karachi, Pakistan: Data from community-based field clinics

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 929-930

  Rafiq, Yasraba ^a   Jabeen, Kauser ^a   Hasan, Rumina ^a   Jafri, Sana ^a   Laiq, Rabia ^a   Malik, Faisal ^a   Mangi, Rafique ^b   Channa, Abid ^b   Hasan, Zahra ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Marie Adelaide Leprosy Center   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ASSESSMENT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTPATIENT DEPARTMENT; PAKISTAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

AMBULATORY CARE FACILITIES; ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDES; PAKISTAN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 78751680761     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00931-10     Document Type: Article

References (13)

1. Agrawal, D., Z. F. Udwadia, C. Rodriguez, and A. Mehta. 2009. Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int. J. Tuberc. Lung Dis. 13:79-83.
2. Butt, Z. A., A. H. Gilani, D. Nanan, A. L. Sheikh, and F. White. 2005. Quality of pharmacies in Pakistan: a cross-sectional survey. Int. J. Qual. Health Care 17:307-313.
3. Centers for Disease Control and Prevention (CDC). 1993. Initial therapy for tuberculosis in the era of multidrug resistance-recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm. Rep. 42:1-8.
4. Duong, D. A., et al. 2009. Beijing genotype of Mycobacterium tuberculosis is associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob. Agents Chemother. 53:4835-4839.
5. Flores, L., et al. 2007. Large sequence polymorphisms classify Mycobacterium tuberculosis strains with ancestral spoligotyping patterns. J. Clin. Microbiol. 45:3393-3395.
6. Honore-Bouakline, S., J. P. Vincensini, V. Giacuzzo, P. H. Lagrange, and J. L. Herrmann. 2003. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J. Clin. Microbiol. 41:2323-2329.
7. Jabeen, K., A. Zafar, E. Khan, S. Irfan, and R. Hasan. 2010. Increase in isolation of ESBL-producing multidrug resistant nontyphoidal salmonellae from Pakistan. BMC Infect. Dis. 10:101.
8. Kamerbeek, J., et al. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
9. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes, 2nd edition. Approved standard M24-A. NCCLS, Wayne, PA.
10. Winn, W. C., et al. 2005. Color atlas and text book of diagnostic microbiology. Lippincott Williams & Wilkins, Philadelphia, PA.
11. World Health Organization. 2009. Treatment of tuberculosis: guidelines. World Health Organization, Geneva, Switzerland.
12. World Health Organization. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. World Health Organization, Geneva, Switzerland.
13. Zafar, A., and K. Jabeen. 2007. Antimicrobial resistance in Neisseria gonorrhoeae and limited treatment options. J. Pak. Med. Assoc. 57:333-334.